[Interview] ICCPP Group: “Five Sense” Vaporization Technology, The Lifeline is Innovation

Innovation
Jun.22.2022
[Interview] ICCPP Group: “Five Sense” Vaporization Technology, The Lifeline is Innovation
2FIRSTS interviewed Jane Lu, the Brand Director of ICCPP Group to reveal the answer.

 Just like the story "other family’s child", ICCPP is the gifted student who has never been partial to subjects, and had handed over full marks all the way on the road of enterprise development. Where does ICCPP’s strong strength come from? What's special about the philosophy of ICCPP’s operators? 2FIRSTS interviewed Jane Lu, the Brand Director of ICCPP Group to reveal the answer.

 

Bringing a Multi-Dimensional Experience to the "Five Senses"

 

In 2014, ICCPP founder Zhao Guanyun, founded ICCPP Technology Co., Ltd. in Shenzhen, focusing on the development of electronic vaporization chips. In 2017, through in-depth market research, the founder team of ICCPP realized that only self-operated brands can get closer to users and better meet customer needs. In that year, the founder team established its own brand, and successfully entered the international market.

 

The transformation of the company is a major event. Of course, it has experienced doubts, but the founder team has a firm strategic direction of its own brand, and started ICCPP’s new story on path.

 

ICCPP brand director, Jane Lu, interprets their products with a unique perspective. She said: "Many people will not see it as high-tech, but as the opposite. Electronic vaporization uses the 'five senses' (taste, vision, hearing, smell, touch) as the starting point to bring consumers a multi-dimensional product experience. The design and development of a product contains cutting-edge technologies in different fields such as basic materials, electronic chips, and life sciences. Consumer may not see it, but technology is in every fiber and process.”

 

ICCPP’s "customer-centered" business philosophy, as well as its comprehensive layout in technological innovation, product development, intelligent manufacturing, and independent brand management, are the key factors to maintaining their high growth. Jane Lu said: "Every company that makes products and serves users down-to-earth will have a place to stand. Only in this way can our doubts be cleared, and our future gradually become brighter."

 

Eight years after its establishment, ICCPP products have been sold in more than 70 countries and regions around the world. The group has 6 branches each in United States, Canada, Germany, the United Kingdom, France, and Indonesia. At present, it has formed a global headcount of more than 6,000 people, and has an independent R&D team of more than 500 people, including more than ten doctors. They have the basic pre-research capabilities with 4 research institutes. Their operations network stretch over 7 major branches and 6 manufacturing centers. Recently, a scientific paper by ICCPP was also published in the Journal of Advanced Research in Fluid Mechanics and Thermal Sciences.

 

Innovation is the Lifeline

 

In 2017, ICCPP created the ignition speed record of 0.0025 second suction at that time with their innovative R&D. Later, each generation of their products had distinctive highlights, and directly or indirectly led the innovation and change of the industry. In this regard, ICCPP’s founder team once said modestly: "Innovation is not simply the product of competition, but the inevitable result of the positive development of the industry."

 

 

In 2020, ICCPP developed into a TOP tier enterprise in the industry. In the past few years, ICCPP had closely carried out innovative materials research in cooperation with many well-known domestic universities. They built a forward-looking R&D system integrating production, learning and research, and built a global compliance team as well as four major research institutions at crazy speeds. Presently, ICCPP has applied for more than 1,000 patents in total and now has the capabilities of the whole industry chain structure.

 

Product innovation has always been the lifeline of ICCPP Technology. Jane Lu introduced: "We built the world's fastest ignition equipment and introduced 'second suction' to the industry as a key indicator. We pioneered a common standard interface for products, redefining the industry's interface manufacturing standards. We developed Gene Tree micro-crystalline Ceramic core, with 0 friction and 0 dust to satisfy users' pure suction experience." ICCPP ultimate goal is to realize "vaporization core standardization, vaporization interface standardization, and vapor equipment integration". As one of the leaders in the field of vapor technology and new material technology, ICCPP will continue to deepen the field of electronic vapor technology in the future, and continue to play a benchmarking role in the industry.

From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Again Meets Religious Authority Over Cigarette Alternatives as Perlis Mufti Responds on Halal Criteria
Philip Morris Malaysia Managing Director Naeem Shahab Khan met Perlis Mufti Mohd Asri Zainul Abidin on September 17 and presented the company's shift from conventional cigarettes toward alternative products. The mufti said a product could be considered halal if it is clean, its side effects are not harmful or can be controlled, and it does not involve excessive waste. His remarks did not mention IQOS or any other specific PMI product and did not amount to a new product-specific religious ruling. It was at least the second publicly reported engagement between Philip Morris Malaysia and a Malaysian religious institution over cigarette alternatives within six months.
Regulations
Sep.18 by 2Firsts Perspectives